MIRA · MIRA Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| Aminov Erez Chief Executive Officer | ▲ Buy | Grant | 3,530,156 Shares held | 10/1/2025 | View profile |
| Cappy George | ▲ Buy | Open Market | 2,859,318 Shares held | 8/7/2023 | View profile |
| McNulty Brian Patrick | ▼ Sell | Open Market | 2,540,270 Shares held | 8/28/2024 | View profile |
| Shekhat Denil Nanji Director | ▲ Buy | Grant | 22,378 Shares held | 10/1/2025 | View profile |
Transaction History
| Shekhat Denil Nanji | ▲ Buy | Grant | 22,378 | $30K | 10/1/2025 |
| Aminov Erez | ▲ Buy | Grant | 2,685,456 | — | 10/1/2025 |
| Aminov Erez | ▲ Buy | Grant | 62,500 | $86K | 8/29/2025 |
| Aminov Erez | ▼ Sell | Open Market | 44,590 | $57K | 11/20/2024 |
| Aminov Erez | ▼ Sell | Open Market | 55,410 | $77K | 11/19/2024 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 200,000 | $392K | 8/28/2024 |
| Aminov Erez | ▲ Buy | Open Market | 2,000 | $2K | 5/21/2024 |
| Aminov Erez | ▲ Buy | Open Market | 1,000 | $1K | 5/21/2024 |
| Aminov Erez | ▲ Buy | Open Market | 500 | $510 | 5/21/2024 |
| Aminov Erez | ▲ Buy | Open Market | 2,000 | $2K | 5/21/2024 |
| Aminov Erez | ▲ Buy | Open Market | 1,000 | $850 | 5/21/2024 |
| Aminov Erez | ▲ Buy | Open Market | 600 | $522 | 5/21/2024 |
| Aminov Erez | ▲ Buy | Open Market | 800 | $808 | 5/21/2024 |
| Aminov Erez | ▲ Buy | Open Market | 800 | $776 | 5/21/2024 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 23,002 | $36K | 12/11/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 23,003 | $36K | 12/11/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 9,527 | $15K | 12/8/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 9,526 | $15K | 12/8/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 16,667 | $32K | 12/7/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 16,666 | $32K | 12/7/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 13,866 | $41K | 12/6/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 13,867 | $41K | 12/6/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 30,666 | $122K | 12/4/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 30,665 | $122K | 12/4/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 2,421 | $9K | 11/30/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 2,421 | $9K | 11/30/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 3,699 | $15K | 11/29/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 3,700 | $15K | 11/29/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 120 | $480 | 11/28/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 121 | $484 | 11/28/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 3,212 | $13K | 11/27/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 3,213 | $13K | 11/27/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 2,500 | $13K | 11/21/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 2,500 | $13K | 11/21/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 13,366 | $68K | 11/20/2023 |
| McNulty Brian Patrick | ▼ Sell | Open Market | 13,367 | $68K | 11/20/2023 |
| Cappy George | ▲ Buy | Open Market | 119,048 | $833K | 8/7/2023 |
| Cappy George | ▲ Buy | Open Market | 157,170 | $1.1M | 8/2/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
MIRA experiences gap up/down in Thursday trading
MIRA was among the stocks that opened higher and later fell during Thursday's session, creating a gap up and gap down pattern. The move coincided with a high‑beta and volume‑spike signal, indicating increased volatility. With an RSI near 51 and support at $0.93, the price is still well above its 52‑week low. Analysts maintain a target of $3.50.
MIRA experiences gap up/down in Thursday trading. MIRA was among the stocks that opened higher and later fell during Thursday's session, creating a gap up and gap down pattern. The move coincided with a high‑beta and volume‑spike signal, indicating increased volatility. With an RSI near 51 and support at $0.93, the price is still well above its 52‑week low. Analysts maintain a target of $3.50.